Maintenance of energy expenditure on high-protein vs. high-carbohydrate diets at a constant body weight may prevent a positive energy balance.
Study Goal
The researchers aimed to determine whether a high-protein low-carbohydrate diet (HPLC) prevents a positive energy balance compared to a high-carbohydrate low-protein diet (HCLP) at a constant body weight, and whether its effects on fullness, energy expenditure, and macronutrient balances are transient or sustained over 12 weeks.
Results Summary
The HPLC diet maintained total energy expenditure (TEE) and energy balance, while the HCLP diet led to decreased TEE and a positive energy balance. Fullness was higher in the HPLC group initially but not sustained at 12 weeks, and protein balance directly reflected dietary protein intake.
Population
14 men and 18 women (mean age 24 ± 5 y, BMI 22.8 ± 2.0 kg/m²).
Effective Dosage
30% protein, 35% carbohydrate, 35% fat (HPLC) vs. 5% protein, 60% carbohydrate, 35% fat (HCLP).
Duration
12 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
high-protein low-carbohydrate (HPLC) diet | no change | total energy expenditure (TEE) | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | maintained | #1 |
high-carbohydrate low-protein (HCLP) diet | decrease | total energy expenditure (TEE) | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | significantly decreased | #2 |
high-protein low-carbohydrate (HPLC) diet | no change | energy balance | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | maintained | #3 |
high-carbohydrate low-protein (HCLP) diet | increase | energy balance | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | became positive | #4 |
high-protein low-carbohydrate (HPLC) diet | increase | protein balance | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | varied directly according to the amount of protein in the diet | #5 |
high-protein low-carbohydrate (HPLC) diet | increase | fullness ratings | 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] | - | were significantly higher | #6 |
BACKGROUND & AIMS: Relatively high-protein diets are effective for body weight loss, and subsequent weight maintenance, yet it remains to be shown whether these diets would prevent a positive energy balance. Therefore, high-protein diet studies at a constant body weight are necessary. The objective was to determine fullness, energy expenditure, and macronutrient balances on a high-protein low-carbohydrate (HPLC) diet compared with a high-carbohydrate low-protein (HCLP) diet at a constant body weight, and to assess whether effects are transient or sustained after 12 weeks. METHODS: A randomized parallel study was performed in 14 men and 18 women [mean ± SD age: 24 ± 5 y; BMI (in kg/m(2)): 22.8 ± 2.0] on diets containing 30/35/35 (HPLC) or 5/60/35 (HCLP) % of energy from protein/carbohydrate/fat. RESULTS: Significant interactions between dietary intervention and time on total energy expenditure (TEE) (P = 0.013), sleeping metabolic rate (SMR) (P = 0.040), and diet-induced thermogenesis (DIT) (P = 0.027) appeared from baseline to wk 12. TEE was maintained in the HPLC diet group, while it significantly decreased throughout the intervention period in the HCLP diet group (wk 1: P = 0.002; wk 12: P = 0.001). Energy balance was maintained in the HPLC diet group, and became positive in the HCLP diet group at wk 12 (P = 0.008). Protein balance varied directly according to the amount of protein in the diet, and diverged significantly between the diets (P = 0.001). Fullness ratings were significantly higher in the HPLC vs. the HCLP diet group at wk 1 (P = 0.034), but not at wk 12. CONCLUSIONS: Maintenance of energy expenditure on HPLC vs. HCLP diets at a constant body weight may prevent development of a positive energy balance, despite transiently higher fullness. The study was registered on clinicaltrials.gov with Identifier: NCT01551238.